๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phytotherapy with permixon modulates steroid pathways in benign prostatic hyperplasia (BPH)

โœ Scribed by Jean-Pierre Raynaud; Catherine Iehle; Sylvie Delos; Pierre-Marie Martin

Book ID
119179417
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
162 KB
Volume
31
Category
Article
ISSN
1043-6618

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Comparison of phytotherapy (Permixonยฎ) w
Comparison of phytotherapy (Permixonยฎ) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients
โœ Carraro, Jean-Christophe; Raynaud, Jean-Pierre; Koch, Gary; Chisholm, Geoffrey D ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 926 KB

BACKGROUND. Controversy regarding the relative efficacy of treatments for the relief of the symptoms of benign prostatic hyperplasia (BPH). METHODS. This was a 6-month double-blind randomized equivalence study that compared the effects of a plant extract (320 mg Permixon") with those of a 5a-reducta

Androgen receptor CAG repeat length poly
Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): Correlation with adenoma growth
โœ Mitsumori, Kenji; Terai, Akito; Oka, Hiroya; Segawa, Takehiko; Ogura, Keiji; Yos ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 169 KB

## Background: The androgen receptor (ar) gene has a polymorphic cag microsatellite encoding variable-length glutamine repeats in the ar protein. the purpose of this study was to evaluate the association between the growth of benign prostatic hyperplasia (bph) and the ar gene cag repeat length. ##